Therapeutic implications of central and peripheral neurologic mechanisms in migraine.
Waeber
Christian
C
Neuroscience Center, Department of Radiology, Massachusetts General Hospital/Harvard Medical School, Charlestown, MA 02129, USA.
Moskowitz
Michael A
MA
D000700:Analgesics / Q000494:pharmacology / Q000627:therapeutic use*; D000818:Animals; D002121:Calcium Channel Blockers / Q000494:pharmacology / Q000627:therapeutic use; D013181:Cortical Spreading Depression / Q000187:drug effects; D006801:Humans; D008578:Meninges / Q000098:blood supply / Q000503:physiopathology; D008881:Migraine Disorders / Q000188:drug therapy* / Q000503:physiopathology / Q000517:prevention & control; D023421:Models, Animal; D009569:Nitric Oxide / Q000502:physiology; D020030:Nitric Oxide Donors / Q000633:toxicity; D017470:Receptors, Glutamate / Q000187:drug effects; D011985:Receptors, Serotonin / Q000187:drug effects / Q000502:physiology; D017366:Serotonin Receptor Agonists / Q000494:pharmacology / Q000627:therapeutic use; D014276:Trigeminal Nerve / Q000187:drug effects / Q000503:physiopathology; D014662:Vasoconstrictor Agents / Q000494:pharmacology / Q000627:therapeutic use; D014666:Vasomotor System / Q000187:drug effects / Q000503:physiopathology
D000700:Analgesics; D002121:Calcium Channel Blockers; D020030:Nitric Oxide Donors; D017470:Receptors, Glutamate; D011985:Receptors, Serotonin; D017366:Serotonin Receptor Agonists; D014662:Vasoconstrictor Agents; D009569:Nitric Oxide